申请人:LILLY CO ELI
公开号:WO2020081282A1
公开(公告)日:2020-04-23
The present invention provides compounds of the Formula I below where R1, R2 and m are as described herein, pharmaceutically acceptable salts of the compounds of Formula 1, and methods of using these compounds and salts for treating patients for cancer.